Long Term Results of High Dose Rate Brachytherapy and External Beam Radiotherapy for Local and Locally Advanced Prostate Cancer

Abstract

Patients with confirmed histological diagnosis Gleason scored (GS) of PCa, AJCC clinical stage T1 to T3a, with no evidence of metastatic disease and initial PSA <60mg/ml, prostate volume <60 cc measured by transrectal ultrasound (TRUS) suitable for EBRT and HDR under spinal anesthesia were eligible. Prior to treatment, patients